Observing vulvar diseases in Nigeria
Official title: Vulvar Disease in Nigeria - Registry ( Observationsl Study)
Run by KDRS ltd · NCT05890092 · Data updated 2026-11-12
This study looks at how much people in Nigeria know about vulvar diseases and how common these conditions really are in different communities.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 10 Years to 90 Years |
| Sex | Women only |
| Enrollment | 1000 (estimated) |
| Sponsor | KDRS ltd Industry-sponsored |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | May 3, 2023 |
| Main results expected | May 2, 2026 |
| Study ends | November 30, 2026 |
| Registry record updated | June 6, 2023 |
| Trial ID | NCT05890092 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are biological females residing in Nigeria.
✕Probably not a fit
Patients who are not biological females will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on understanding the awareness and prevalence of vulvar diseases among patients and health practitioners in Nigeria. It aims to gather self-reported data and compare it with actual prevalence rates within various communities. By observing these factors, the study seeks to highlight gaps in knowledge and care regarding vulvar health. The methodology involves collecting data through surveys and community outreach.
Why it matters
Potential benefit: If successful, this study could enhance awareness and improve healthcare practices related to vulvar diseases in Nigeria.
How similar studies have gone: While there may be limited studies specifically focused on vulvar diseases in Nigeria, observational studies in similar contexts have shown success in raising awareness and improving health outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * biological females - afab Exclusion Criteria: * none-afab
Where it's running
-
Kdrs
London, United Kingdom Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Vaginitis Diagnostic Algorithm Pilot Using Nanopath and Other Tests
This study tests a new Nanopath vaginal test to see if it correctly detects vaginitis-causing pathogens in up to 1,000 people with vaginitis symptoms.
-
Pixel CO2 (FemiLift) laser treatment for vulvo-vaginal atrophy
This trial tests whether the Pixel CO2 (FemiLift) laser can relieve symptoms and restore healthier vaginal tissue in postmenopausal women with vulvo-vaginal atrophy.
-
Nonhormonal vulvovaginal gel to relieve menopausal vulvovaginal symptoms
This will test a hormone-free vulvovaginal gel in postmenopausal women with genitourinary syndrome of menopause to see if it reduces vaginal atrophy symptoms and improves daily quality of life.
-
Investigation of recurrence detection in vulva cancer patients
This study is testing how well doctors can detect if vulva cancer comes back in women by looking at their symptoms and checking for cancer DNA in their blood over two years.
-
Topical treatment for high-grade vulvar lesions
This study is testing a new ointment to see if it can help women with high-grade vulvar lesions caused by HPV without needing surgery.
-
Evaluating vulvovaginitis effects on surgical outcomes after vulvar excision
This study is testing how common vulvovaginitis is in women having surgery for non-cancerous vulvar conditions and whether it affects their recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.